Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department
Alberto M Cappellari1, Stefania Margiotta2, Gaia Bruschi2
1Department of Neuroscience and Mental Health, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Insights
The COVID-19 pandemic significantly reduced pediatric emergency department visits for headaches. This study highlights a notable decrease in headache evaluations during the pandemic, particularly for secondary headaches.
Area of Science:
- Pediatric Emergency Medicine
- Epidemiology
- Public Health
Background:
- Headache is a common presenting symptom in pediatric emergency departments (EDs).
- The COVID-19 pandemic has been associated with changes in healthcare utilization patterns.
- The impact on pediatric headache evaluations in the ED remains unclear.
Purpose of the Study:
- To assess the effect of the COVID-19 pandemic on pediatric ED evaluations for headache.
- To quantify changes in headache evaluation rates before and during the pandemic.
Main Methods:
- Retrospective analysis of pediatric ED visits for headache from January 2017 to January 2022.
- Comparison of evaluation rates between the prepandemic (January 2017-February 2020) and pandemic (March 2020-January 2022) periods.
- Incidence rate ratios (IRR) and 95% confidence intervals (CI) were calculated to quantify the impact.
Main Results:
- A total of 890 headache evaluations were registered (689 prepandemic, 201 pandemic).
- Monthly evaluation rates decreased from 18.1 (prepandemic) to 8.7 (pandemic), an IRR of 0.49.
- The reduction was more pronounced for secondary headaches (IRR 0.31) than primary headaches (IRR 0.56).
Conclusions:
- The COVID-19 pandemic led to a substantial decrease in pediatric emergency department visits for headache.
- This reduction was observed for both primary and secondary headache types, with a greater impact on secondary headaches.
- Further research is needed to understand the long-term implications of these changes in healthcare seeking behavior.
Background:
To evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom.
Methods:
Number and clinical features of patients evaluated in the pediatric ED of a single site in Milan, Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).
Results:
During the study period, 890 evaluations were registered: 689 over the prepandemic period and 201 over the pandemic period. Mean age at evaluation was 10 years (range: 1 to 17 years). Evaluation rates per month were 18.1 during the prepandemic period and 8.7 during COVID-19 pandemic, with peaks in autumn and winter months and considerable drops in the summer. The IRR was 0.49 (95% CI, 0.40-0.61). The reduction in evaluation rate was higher for secondary headache (IRR, 0.31; 95% CI, 0.23-0.42) when compared with primary headache (IRR, 0.56; 95% CI, 0.40-0.78).
Conclusions:
We found a remarkable reduction in the number of evaluations in the pediatric ED for headache during the pandemic period.
Related Concept Videos
Tonsillitis II: Management
Viral Meningitis
Arboviral Encephalitis
Inhibitors of Viral Protein Synthesis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology


